Anthropic Stock News: Greenshoe Used Up in 1 Day, What Next for ANT?
Anthropic's underwriters exercised their greenshoe option, buying 147 million additional shares at $83, increasing the total offering to 1.13 billion shares. The company raised $93.5 billion. ANT stock fell 8.5% to $88.91 on Friday, closing above the IPO price. The market cap is estimated at $1.19 trillion. The next catalyst may be Monday's trading session and potential early unlocking of 3.7 billion shares.
How this was made

The 30-second read
Why it matters
For ANT, the key trading question is whether full greenshoe use meaningfully changes near-term downside risk or whether it is largely mechanical and already priced after listing.
Market read
Traders may reassess ANT’s post-IPO downside cushion and stabilization narrative into the next session, but the article provides no confirmed causal link to the price drop.
What to watch
The article itself flags lack of confirmed causality for the Friday drop, so broader market/AI sentiment and general post-IPO profit-taking could be the dominant drivers rather than greenshoe mechanics.
Background
The article explains greenshoe (over-allotment) options and claims Anthropic’s underwriters exercised the full additional-share option at the offer price.
Ticker impact
Article says Anthropic underwriters bought the full 147M greenshoe shares at $83, and discusses whether that removes a cushion for ANT after a post-listing drop.
Likely near-term volatility around Monday’s open as traders reassess whether the greenshoe was a meaningful stabilizer versus a one-off listing mechanic.
The piece provides specific greenshoe mechanics and ties them to a post-listing price slide, but it also admits no official source confirms the greenshoe as the cause of the move.
Market effects
Limited direct read-through to the broader AI/IPO market, but it can influence how traders price IPO stabilization mechanics for other high-profile listings.
Mostly US-focused via Nasdaq trading and IPO mechanics; crypto outlet framing suggests cross-asset risk appetite comparisons.
Low, as the story is specific to a single US-listed IPO and its underwriter over-allotment.
Counterpoint
The greenshoe being fully used may not be a bearish signal; it could simply mean demand was strong enough for underwriters to cover without needing additional market support.
Key entities
- companyAnthropic
Subject of the article, discussed via its IPO greenshoe exercise and subsequent ANT trading.
- underwriterGoldman Sachs
Named as a lead underwriter in the greenshoe/IPO deal mechanics.
- underwriterMorgan Stanley
Named as a lead underwriter and referenced in the tweet claim about full option use.



